Your browser doesn't support javascript.
loading
Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.
Pierce, Stuart R; Stine, Jessica E; Gehrig, Paola A; Havrilesky, Laura J; Secord, Angeles A; Nakayama, John; Snavely, Anna C; Moore, Dominic T; Kim, Kenneth H.
Afiliación
  • Pierce SR; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States. Electronic address: Stuart.Pierce@unchealth.unc.edu.
  • Stine JE; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States.
  • Gehrig PA; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
  • Havrilesky LJ; Duke University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.
  • Secord AA; Duke University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.
  • Nakayama J; Duke University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.
  • Snavely AC; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
  • Moore DT; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
  • Kim KH; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
Gynecol Oncol ; 144(3): 531-535, 2017 03.
Article en En | MEDLINE | ID: mdl-28062116
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias Uterinas / Neoplasias de la Mama / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar / Antagonistas de Estrógenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias Uterinas / Neoplasias de la Mama / Cistadenocarcinoma Seroso / Cistadenocarcinoma Papilar / Antagonistas de Estrógenos Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged País/Región como asunto: America do norte Idioma: En Revista: Gynecol Oncol Año: 2017 Tipo del documento: Article